ArticleMedChemComm2017

Rational design and optimization of selenophenes with basic side chains as novel potent selective estrogen receptor modulators (SERMs) for breast cancer therapy.

Junjie Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.